
FDA approves presbyopia drop
Qlosi, Orasis Pharmaceuticals’ preservative-free 0.4% pilocarpine formulation, has received US Food and Drug Administration (FDA) approval for the treatment of presbyopia in adults. The company’s ph

Qlosi, Orasis Pharmaceuticals’ preservative-free 0.4% pilocarpine formulation, has received US Food and Drug Administration (FDA) approval for the treatment of presbyopia in adults. The company’s ph

A US study has shown optometrist-performed Nd:YAG laser capsulotomies to be safe and effective.

The first fully, immediately sequential, bilateral-cataract surgery (ISBCS) theatre list in the UK was completed at the start of November at the Nightingale Hospital in Exeter by Dr Harry Roberts.

Standing out from more than 1,490 in-person delegates (with a further 240 tuning in online) at this year’s RANZCO Congress in Perth were the 2023 new graduating fellows and many award winners.

US researchers have developed a technique to ‘guide’ blood-derived stem cells to mouse retinas to replace retinal ganglion cells (RGCs) lost to glaucoma. Donor stem cells injected into the eye

A recent study found Nova Eye Medical’s iTrack ab-interno canaloplasty microcatheter significantly reduced intraocular pressure (IOP) and medication requirements for patients with primary open-angle g

A Vietnamese study has shown how non-ophthalmic healthcare workers could detect signs of glaucoma from retinal images with an accuracy comparable with ophthalmologists after completing a short online

Moorfields has announced it will explore a possible new treatment for retinal detachment surgery complicated by scar tissue from proliferative vitreoretinopathy (PVR), the most common cause of retinal

A UK study found that since Black and South Asian diabetics were more likely to develop sight-threatening diabetic retinopathy (STDR), standard biennial screening would have delayed detection of some

LINKS: https://nzoptics.co.nz/articles/archive/red-light-therapy-for-myopia-control/In response to a young patient of Chinese ethnicity developing temporary vision loss and recoverable retinal damage

After more than five years and four applications, Southern Cross has added minimally invasive glaucoma surgery devices to its members’ policies...

Featuring 73-year-old veteran artist Reba Pal painting chalachitra, a Bengali art form from East India, the professional award of the 2023 World Sight Day Photo Competition was won by Santanu Bose, while Marisa Martins Armada won the amateur category for her picture, ‘The Smile of Happiness’.